SMI
11.791,91
PKT
-135,20
PKT
-1,13
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
30.03.21 | UBS Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.03.21 | Zurich Insurance overweight | Barclays Capital | |
30.03.21 | UBS Neutral | Goldman Sachs Group Inc. | |
29.03.21 | Givaudan Hold | Deutsche Bank AG | |
29.03.21 | UBS kaufen | DZ BANK | |
26.03.21 | Nestlé buy | Goldman Sachs Group Inc. | |
25.03.21 | Holcim Hold | Jefferies & Company Inc. | |
25.03.21 | UBS Outperform | Credit Suisse Group | |
24.03.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
24.03.21 | Roche overweight | Barclays Capital | |
24.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
24.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
23.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis buy | Jefferies & Company Inc. | |
23.03.21 | Novartis market-perform | Bernstein Research | |
23.03.21 | Roche Outperform | Bernstein Research | |
23.03.21 | UBS kaufen | DZ BANK | |
23.03.21 | Roche Neutral | UBS AG | |
23.03.21 | Roche Hold | Deutsche Bank AG | |
23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
22.03.21 | Roche overweight | Barclays Capital | |
22.03.21 | Novartis market-perform | Bernstein Research | |
22.03.21 | Roche Neutral | UBS AG | |
22.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
22.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
19.03.21 | Holcim overweight | JP Morgan Chase & Co. | |
18.03.21 | UBS overweight | JP Morgan Chase & Co. | |
18.03.21 | Nestlé overweight | JP Morgan Chase & Co. | |
17.03.21 | UBS Neutral | UBS AG | |
17.03.21 | UBS Hold | Kepler Cheuvreux | |
17.03.21 | Nestlé overweight | Morgan Stanley | |
17.03.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
16.03.21 | UBS Outperform | Credit Suisse Group | |
16.03.21 | UBS Sector Perform | RBC Capital Markets | |
16.03.21 | UBS overweight | JP Morgan Chase & Co. | |
16.03.21 | Roche Hold | Jefferies & Company Inc. | |
15.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.03.21 | Roche Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.